Immulox is produced exclusively by APS BioGroup using a proprietary, patented process (US Patent No. US7,547,770B2). It is sold as a health supplement in the United States. In some countries Immulox Spray is sold as a drug for the treatment of immune disorders.*
Immulox liquid is delivered using a unique and effective spray system. With this system, the PRPs and other immune factors are absorbed quickly in the digestive tract because the 80+ identified peptides are less than 5,000 Daltons (molecular weight).
The isolation of PRPs in Immulox Spray increases the mass transfer coefficient of these peptides for absorption, because no other dairy proteins and fats are present in Immulox Spray. Once absorbed, PRPs signal activated T-cells and activated macrophages, which are the cytokine factories in mammalian bodies. A balanced or modulated production of cytokines by these activated T-cells and activated macrophages send the correct signals to other human cells not to overreact or underperform in their immune actions.* Learn more about Immulox benefits and references.
Contact us for information on Immulox Spray availability and international distribution opportunities.
* These statements have not been evaluated by the US Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.